Skip to main content

A Pilot Study of Efficacy and Safety of Continuous Intravenous Infusion of Pantoprazole in the Treatment of Severe Erosive Esophagitis

Digestive Diseases and Sciences volume 53, pages 1500–1505 (2008)Cite this article

Abstract

Background and objectives Reflux esophagitis is a common disease. Erosive reflux esophagitis is a more advanced stage of reflux esophagitis. Although death from reflux disease is uncommon, significant morbidity and mortality from complications, such as esophageal ulcer, stricture, and cancer, are not uncommon. Proton pump inhibitors are the popular medication for reflux esophagitis. The objective of this study was to determine the efficacy and safety of continuous intravenous infusion of pantoprazole in the treatment of severe erosive esophagitis. Methods From February 2005 to November 2006, all patients with grade 4 erosive reflux esophagitis were screened for the study. Eligible patients were randomized into two groups. Each patient in the study group received intravenous pantoprazole 80 mg loading dose over 5 min, followed by 8 mg/h intravenous infusion for 72 h, then 40 mg orally once a day for 4 days. Each patient in the control group received 40 mg pantoprazole intravenously once a day for 72 h, then orally once a day for 4 days. A second endoscopic gastrointestinal examination (EGD) was performed on treatment days 6–8 (±1 day if day 7 was on a weekend) to document any healing of esophagitis in either the study or the control group. Results In the study group, severe erosive esophagitis healed completely in three patients and significantly in the other three by the time of the second endoscopy. In the control group, severe erosive esophagitis healed partially in five patients, and no improvement was seen at all in one patient by the time of second endoscopy. The difference in the intervention between those two groups was statistically different (P = 0.015). There were no significant complications in either group. Conclusions Severe erosive esophagitis can be completely healed in a few days if pantoprazole is given intravenously and continuously for 72 h. It is safe to give pantoprazole intravenously and continuously for treatment of severe erosive esophagitis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Orlando RC (1995) Reflux esophagitis. In: Yamada T et al (eds) Textbook of gastroenterology, 2nd edn. J.B. Lippincott, Philadelphia

    Google Scholar 

  2. Orlando RC, Powell DW, Carney CN (1981) Pathophysiology of acute acid injury in rabbit esophageal epithelium. J Clin Invest 68:286–291

    PubMed  Article  CAS  Google Scholar 

  3. Hopwood D, Milne G, Logan KR (1979) Electron microscopic changes in human esophageal epithelium in esophagitis. J Pathol 129:161–165

    PubMed  Article  CAS  Google Scholar 

  4. Spechler SJ (1992) Epidemiology and natural history of gastroesophageal reflux disease. Digestion 51:24–33

    PubMed  Article  Google Scholar 

  5. Ritcher JE, Kahrilas PJ, Johanson J et al (2001) Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 96:656–665

    Article  Google Scholar 

  6. Castell DO, Kahrilas PJ, Richter JE et al (2002) Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97:575–583

    PubMed  Article  CAS  Google Scholar 

  7. Richter JE, Bochenek W, The Pantoprazole US GERD Study Group (2000) Oral pantoprazole for erosive esophagitis: A placebo-controlled, randomized clinical trial. Am J Gastroenterol 95:3071–3080

    Google Scholar 

  8. Kovacs TOG, Wilcox CM, Devault K, Miska D, Bochenek W, The Pantoprazole US GERD study group (2002) Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive esophagitis: a randomized, active-controlled, double-blind study. Aliment Pharmacol Ther 16:2034–2052

    Google Scholar 

  9. Anonymous (2000) Pantoprazole (Protonix). Med Lett Drugs Ther 42:65–66

  10. Lew ES, Pisegna JR et al (2000) Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger–Ellison syndrome. Gastroenterology 118:696–703

    PubMed  Article  CAS  Google Scholar 

  11. Van Rensburg CJ, Hartmann M, Thorpe A, Venter L, Theron I, Luhmann R, Wurst W (1999) Intravenous pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 98:2635–2641

    Article  Google Scholar 

  12. Jensen DM, Pace SC, Soffer E, Comer GM, Members of the 315 study group (2006) Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. Am J Gastroenterol 101:1991–1999

    Google Scholar 

  13. Paul J, Metz D et al (1998) Pharmacodynamic equivalence of oral and i.v. pantoprazole in GERD patients. Am J Gastroenterol 93:1622, A53

    Google Scholar 

  14. Metz DC, Pratha V, Martin P, Paul J, Maton PN, Lew E, Pisegna JR (2000) Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. Am J Gastroenterol 95:626–633

    PubMed  Article  CAS  Google Scholar 

  15. Pratha V, Hogan DL, Lynn RB, Field B, Metz DC (2006) Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Dig Dis Sci 51:1595–1601

    PubMed  Article  CAS  Google Scholar 

  16. Dabney-Smith K, Nam J, Ghazale A, Cai Q (2003) Severe esophagitis healed in less than a week with intravenous pantoprazole. J Clin Gastroenterol 36:78–79

    PubMed  Article  Google Scholar 

  17. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCathy JH (1988) Healing and replase of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903–912

    PubMed  CAS  Google Scholar 

  18. Rosner B (2000) Fundamentals of biostatistics, 5th edn. Duxbury Press, Pacific Grove, California

    Google Scholar 

  19. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptoms relief in grade II to IV gastroesophagea reflux disease: a meta-analysis. Gastroenterology 112:1798–1810

    PubMed  Article  CAS  Google Scholar 

  20. Silverstein FE, Tytgat GNT (1997) Gastrointestinal endoscopy, 3rd edn. Mosby-Wolfe

  21. Erstad BL (2004) Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding. Crit Care Med 32:1415–1416

    Article  Google Scholar 

  22. Lau JYW, Sung JJY, Lee KKC, Yung MY, Wong SKH, Wu JCY, Chan FKL, Ng EKW, You JHS, Lee CW, Chan ACW, Chung SCS (2000) Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343:310–316

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a research grant from Wyeth Pharmaceuticals Inc.

Author information

Affiliations

  1. Division of Digestive Diseases, Emory University School of Medicine, 1365 Clifton Road, Suite B1262, Atlanta, GA, 30322, USA

    Qiang Cai, Mahmoud Barrie, Henry Olejeme & Marc D. Rosenberg

Authors
  1. Qiang Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahmoud Barrie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henry Olejeme
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marc D. Rosenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang Cai.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cai, Q., Barrie, M., Olejeme, H. et al. A Pilot Study of Efficacy and Safety of Continuous Intravenous Infusion of Pantoprazole in the Treatment of Severe Erosive Esophagitis. Dig Dis Sci 53, 1500–1505 (2008). https://doi.org/10.1007/s10620-007-0044-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-0044-6

Keywords

  • Esophagitis
  • Proton pump inhibitors
  • Acid suppressive therapy
  • Protonix